Monopar Therapeutics (MNPR)
Across 21 earnings reports since May 13, 2021, Monopar Therapeutics (MNPR) has a clear post-earnings pattern. It moves ±6.14% on average after reporting and finishes higher 42.9% of the time. Its largest post-earnings gain was +14.55% (Aug 12, 2025) and its largest decline was -24.83% (Nov 10, 2022). The next earnings report is predicted for 2026-08-10 (estimated).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±6.14%
Positive %
42.9%
Negative %
57.1%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | ☽ POST | $59.13 | $61.86 | $61.21 | 15,434 | -2.96% | open_in_new |
| Mar 27, 2026 | ☽ POST | $54.40 | $57.47 | $54.10 | 184,300 | -1.5% | open_in_new |
| Nov 13, 2025 | ☀ PRE | $81.96 | $89.03 | $87.01 | 150,500 | +5.36% | open_in_new |
| Aug 12, 2025 | ☀ PRE | $30.90 | $35.90 | $35.90 | 31,800 | +14.55% | open_in_new |
| May 13, 2025 | ☀ PRE | $35.10 | $37.87 | $33.82 | 21,000 | -3.65% | open_in_new |
| Mar 31, 2025 | ☀ PRE | $38.72 | $39.51 | $36.41 | 43,400 | -9.72% | open_in_new |
| Nov 08, 2024 | ☀ PRE | $16.40 | $17.79 | $16.88 | 158,200 | +7.31% | open_in_new |
| Aug 09, 2024 | ☀ PRE | $2.40 | $2.40 | $2.21 | 78,840 | -19.64% | open_in_new |
| May 09, 2024 | ☀ PRE | $3.90 | $4.00 | $3.56 | 10,280 | -5.2% | open_in_new |
| Mar 28, 2024 | ☀ PRE | $3.50 | $3.67 | $3.40 | 58,160 | -7.6% | open_in_new |
| Nov 09, 2023 | ☀ PRE | $2.13 | $2.13 | $2.08 | 24,240 | -3.03% | open_in_new |
| Aug 10, 2023 | ☀ PRE | $3.38 | $3.80 | $3.75 | 59,600 | +3.17% | open_in_new |
| May 11, 2023 | ☀ PRE | $4.95 | $5.15 | $4.67 | 15,600 | -6.6% | open_in_new |
| Mar 23, 2023 | ☀ PRE | $13.85 | $13.85 | $13.73 | 2,340 | +0.62% | open_in_new |
| Nov 10, 2022 | ☀ PRE | $21.95 | $22.43 | $16.50 | 21,640 | -24.83% | open_in_new |
| Aug 11, 2022 | ☀ PRE | $9.05 | $10.95 | $9.15 | 2,340 | +0.27% | open_in_new |
| May 12, 2022 | ☽ POST | $9.89 | $9.89 | $9.25 | 21,100 | +9.19% | open_in_new |
| Mar 24, 2022 | ☀ PRE | $13.05 | $13.45 | $13.15 | 360 | -1.13% | open_in_new |
| Nov 12, 2021 | ☀ PRE | $24.25 | $25.00 | $25.00 | 4,600 | -0.2% | open_in_new |
| Aug 12, 2021 | ☀ PRE | $24.50 | $25.05 | $24.75 | 4,120 | +1.23% | open_in_new |
| May 13, 2021 | ☽ POST | $26.20 | $26.30 | $25.25 | 3,980 | +1.19% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±6.14%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260529 | open_in_new SEC.gov |
| 8-K | 20260519 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260515 | open_in_new SEC.gov |
| 10-Q | 20260514 | open_in_new SEC.gov |
| 8-K | 20260514 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260513 | open_in_new SEC.gov |
| ARS | 20260430 | open_in_new SEC.gov |
| DEF 14A | 20260430 | open_in_new SEC.gov |
| DEFA14A | 20260430 | open_in_new SEC.gov |
| 8-K | 20260420 | open_in_new SEC.gov |
Frequently asked about MNPR earnings
When does Monopar Therapeutics report earnings next? expand_more
Monopar Therapeutics (MNPR)'s next earnings date is estimated for 2026-08-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does MNPR stock move after earnings? expand_more
Over 21 reports, MNPR has moved an average of ±6.14% the session after earnings, closing higher 42.9% of the time.
What was MNPR's biggest post-earnings move? expand_more
MNPR's largest post-earnings gain on record was +14.55% on Aug 12, 2025, and its largest decline was -24.83% on Nov 10, 2022.
Where can I find Monopar Therapeutics's SEC filings? expand_more
All of Monopar Therapeutics's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right